Literature DB >> 1757477

Regulation of expression of the growth-state-related genes 2F1 and 2A9 during entry of quiescent smooth muscle cells into the cell cycle.

M S Kindy1, K E Brown, G E Sonenshein.   

Abstract

Vascular smooth muscle cells (SMCs) play a key role in the development of major arteries. Furthermore, abnormal growth of vascular smooth muscle cells has been implicated in the progression of major diseases of the cardiovascular system. Here, we report detection in primary cultures of bovine vascular smooth muscle cells of mRNA for two growth-state-related genes, 2F1 and 2A9, which code for a mitochondrial ADP/ATP carrier and calcyclin, respectively, and on the characterization of their cell cycle expression. Cultures of exponentially growing smooth muscle cells were made quiescent by serum deprivation. Upon readdition of serum, cells entered the cell cycle synchronously; DNA synthesis began 12 h post-serum addition. Levels of 2F1 and 2A9 RNA were low in quiescent cells and increased between 2 and 4 h post-serum addition. No changes in the rates of transcription of the 2F1 or 2A9 genes were detected by nuclear run-off assays during the time course. Thus the regulation of changes in expression of 2F1 and 2A9 in early G1 is mediated post-transcriptionally.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757477     DOI: 10.1002/jcb.240460409

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes.

Authors:  M M Clowes; C M Lynch; A D Miller; D G Miller; W R Osborne; A W Clowes
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

2.  Biogenesis and dynamics of mitochondria during the cell cycle: significance of 3'UTRs.

Authors:  Marta Martínez-Diez; Gema Santamaría; Alvaro D Ortega; José M Cuezva
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.